256 related articles for article (PubMed ID: 21415579)
1. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
[TBL] [Abstract][Full Text] [Related]
2. Need for immunization against hepatotropic viruses in children with chronic liver disease.
Srivastava A; Mathias A; Yachha SK; Agarwal J; Aggarwal R
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):393-7. PubMed ID: 24840513
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis A in patients with chronic liver disease.
Saab S; Lee C; Shpaner A; Ibrahim AB
J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
Özden HT
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
6. HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.
da Silva EF; Mazo DF; Oliveira CP; Medeiros RP; Carrilho FJ; Pessôa MG
Ann Hepatol; 2016; 15(5):691-5. PubMed ID: 27493107
[TBL] [Abstract][Full Text] [Related]
7. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran.
Ahmadi Vasmehjani A; Javeshghani D; Baharlou R; Shayestehpour M; Mousavinasab SD; Joharinia N; Enderami SE
Epidemiol Infect; 2015 Feb; 143(3):534-9. PubMed ID: 24742346
[TBL] [Abstract][Full Text] [Related]
9. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.
Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH
Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182
[TBL] [Abstract][Full Text] [Related]
10. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
11. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with anti-hepatitis A virus immunoglobulin G seropositivity among Korean workers: a cross-sectional study.
Mun E; Lee Y; Suh B; Kim W; Jeong J; Park H; Lee W; Han B; Park S; Lee C
BMJ Open; 2020 Jun; 10(6):e036727. PubMed ID: 32513893
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.
Acikgoz A; Cimrin D; Kizildag S; Esen N; Balci P; Sayiner AA
BMC Infect Dis; 2020 Jul; 20(1):529. PubMed ID: 32698841
[TBL] [Abstract][Full Text] [Related]
15. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory.
Cho SE; Kim Y
J Epidemiol; 2013; 23(4):270-4. PubMed ID: 23629647
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of anti-HAV among patients with chronic viral liver disease.
Cho HC; Paik SW; Kim YJ; Choi MS; Lee JH; Koh KC; Yoo BC; Son HJ; Kim SW
World J Gastroenterol; 2011 Jan; 17(2):236-41. PubMed ID: 21245998
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol.
Roushan MR; Bijani A; Sagheb R; Jazayeri O
East Mediterr Health J; 2007; 13(5):1108-13. PubMed ID: 18290404
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
20. The seroepidemiology of hepatitis A and B in a Japanese town.
Akbar SM; Onji M; Kanaoka M; Horiike N; Michitaka K; Masumoto T; Nonaka T; Kanda K; Kajino K; Kumamoto I
Asia Pac J Public Health; 1992-1993; 6(2):26-9. PubMed ID: 1339221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]